Smoking increases tissue factor expression in atherosclerotic plaques - Implications for plaque thrombogenicity

Citation
S. Matetzky et al., Smoking increases tissue factor expression in atherosclerotic plaques - Implications for plaque thrombogenicity, CIRCULATION, 102(6), 2000, pp. 602-604
Citations number
13
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
CIRCULATION
ISSN journal
00097322 → ACNP
Volume
102
Issue
6
Year of publication
2000
Pages
602 - 604
Database
ISI
SICI code
0009-7322(20000808)102:6<602:SITFEI>2.0.ZU;2-U
Abstract
Background-Smoking increases the risk of atherothrombotic events. To determ ine whether smoking influences plaque thrombogenicity, we examined the effe ct of cigarette smoking and aspirin use on tissue factor (TF) expression in atherosclerotic plaques. Methods and Results-A total of 23 apoE-/- mice were exposed to cigarette sm oke with (n=9) or without (n= 14) aspirin treatment. Eleven mice who were e xposed to filtered room air served as controls. Aortic root plaques of mice exposed to smoke had higher immunoreactivity for TF (14 +/- 4% versus 6.4 +/- 3%; P=0.0005), vascular cell adhesion molecule-1 (15+/-4% versus 5+/-2% ; P=0.002), and macrophages (16+/-5% versus 6+/-2%; P=0.002) compared with nonsmoking controls. Aspirin treatment attenuated smoking-induced changes i n plaque composition. In human plaques obtained by carotid endarterectomy, TF immunoreactivity ((8+/-5% versus 2+/-2%; P=0.0002) and activity (P=0.03) were higher in the plaques from smokers (n=28) than those from nonsmokers (n=28). Aspirin use was associated with reduced TF expression in smokers (9 +/-8% versus 3+/-4%; P=0.0017). Conclusions-Our results suggest increased plaque TF expression and thrombog enicity as a novel mechanism for the increased risk of atherothrombotic eve nts in smokers. Treatment with aspirin may reduce TF expression.